#Life Sciences

Mubadala to acquire Kelix Bio Image WAM

Mubadala to acquire international biopharma firm KELIX bio

KELIX bio, founded in November 2020, has swiftly emerged as a key player in the pharmaceutical industry, offering more products to markets across the Middle East, Africa and Asia

How life sciences will define the next chapter in the Middle East transformation story

Life science companies are in a unique position to work with local governments to support capacity-building around early diagnosis and treatment

How biotechnology and life sciences are fuelling UAE’s healthcare ambitions

Role of biotechnology and life sciences in UAE’s healthcare ambitions

AI, advanced data management and security privacy have played a fundamental role in reimagining the future of healthcare

Department of Health - Abu Dhabi

Department of Health – Abu Dhabi and biopharma firm MSD GCC announce collaboration

Both the DoH and MSD share a vision of improving the health and wellness of UAE, through innovative medicines and vaccines and other healthcare services

Abu Dhabi’s Mubadala to invest £800m in UK life sciences sector

Joint investment programme with UK govt to devote £1bn to the sector